Tag: angina market share

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Angina Market Expected To Become By 2029 Compared With Its 2025 Level?

The angina market size has observed substantial expansion in recent years. It is anticipated to increase from $10.71 billion in 2024 to $11.36 billion in 2025, showing a compound annual growth rate (CAGR) of 6.1%. This growth during the past period is attributable to the heightened prevalence of coronary heart disease, greater use of vasodilators, an increase in myocardial ischemia prevalence, advancements in diagnostic capabilities, and a rise in the application of imaging techniques.

The angina market is projected to experience robust expansion in the coming years, reaching a valuation of $14.18 billion by 2029, driven by a compound annual growth rate (CAGR) of 5.7%. This anticipated growth during the forecast period is primarily fueled by factors such as the increasing incidence of chronic angina pectoris, a surge in drug approvals and clinical research initiatives, an escalating demand for retail pharmacy services, heightened awareness regarding cardiovascular health, and a rising need for relevant medications. Key trends expected to shape the market over the forecast period encompass technological progress in early diagnostic methods, innovations in angioplasty and stenting procedures, the emergence of novel gene therapy approaches, a persistent demand for coronary stents, and significant improvements in coronary artery disease treatment.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Which Drivers Are Impacting The Angina Market?

The angina market is projected to expand due to the rising incidence of coronary artery diseases. Coronary artery disease (CAD), also recognized as coronary heart disease (CHD) or ischemic heart disease (IHD), is a medical condition marked by the narrowing or obstruction of the coronary arteries, which are essential for delivering blood, oxygen, and nutrients to the heart muscle. The increasing occurrences of coronary artery disease (CAD) are attributed to lifestyle modifications, as well as environmental and genetic factors. Angina plays a crucial function in recognizing and comprehending the widespread presence of coronary artery disease; its manifestation prompts medical assessment and diagnosis, assists in stratifying risk, guides therapeutic choices, and informs public health approaches. For example, according to the American Heart Association in January 2023, the number of adults in the U.S. living with Coronary artery disease (CAD) climbed from 18.2 million in 2021 to an estimated 19.3 million in 2022. Consequently, the growing number of coronary artery disease cases is a significant impetus for the angina market.

What Are The Emerging Segments Gaining Attention In The Angina Market?

The anginamarket covered in this report is segmented –

1) By Type: Angina Pectoris; Unstable Angina; Prinzmetal Angina; Other Types

2) By Treatment: Lifestyle Changes; Medications; Angioplasty And Stenting; Coronary Bypass Surgery; Other Treatments

3) By Drug Class: Beta Blockers; Nitrates And Calcium Channel Blockers; Angiotensin-Converting Enzyme Inhibitors; Other Drug Classes

4) By Application: Clinics; Hospitals; Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina; Chronic Stable Angina; Effort-Induced Angina; Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina; Pre-Infarction Angina; Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina; Coronary Artery Spasm-Induced Angina; Variant Angina

4) By Other Types: Nocturnal Angina; Post-Infarction Angina; Angina With Silent Myocardial Ischemia; Angina Due To Aortic Stenosis Or Valve Disease

Which Key Trends Are Expected To Influence The Angina Market In The Coming Years?

Leading companies within the angina market are focused on developing innovative drugs, such as metoprolol tartrate tablets, to offer more effective and targeted treatments for patients suffering from coronary artery disease (CAD) and related conditions. Metoprolol tartrate tablets represent a medication commonly employed for various cardiovascular ailments, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, obtained final approval from the United States Food and Drug Administration (US-FDA) for the manufacturing and marketing of its generic version of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol is classified as a beta blocker and is utilized for treating diverse cardiovascular conditions, encompassing high blood pressure (hypertension) and chest pain (angina), and to enhance survival rates following a heart attack.

Who Are The Primary Competitors In The Global Angina Market?

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

How Does The Angina Market Perform Across Key Geographic Regions?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Angina Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Browse Through More Reports Similar to the Global Angina Market 2025, By The Business Research Company

Medical Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-software-global-market-report

Generative Ai In Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Clinical Nutrition For Diabetes Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-nutrition-for-diabetes-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Angina Market Size Shifted, And What Is the Outlook Through 2034?

The market size of angina has seen significant expansion lately. It’s forecasted to rise from $10.71 billion in 2024 to $11.36 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this historical growth include a rise in the occurrence of coronary heart disease, escalated usage of vasodilators, an increasing incidence of myocardial ischemia, enhancements in diagnostic methods, and an uptick in the implementation of imaging techniques.

Expectations are high for the angina market to experience considerable growth in the coming years. It’s projected to amass to$14.18 billion by 2029, with a compound annual growth rate (CAGR) of 5.7%. This forecasted growth can be linked to the rising prevalence of chronic angina pectoris, an increase in drug approvals and clinical research, a growing demand from retail pharmacies, increased cardiovascular health awareness, and an ever-growing need for medication. The forecast period will see trends like technological leaps in early diagnosis, improved procedures in angioplasty and stenting, novel gene therapy methods, a rising demand for coronary stents, and progress in treating coronary artery disease.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

What are the Fundamental Drivers and Innovations Shaping the Angina Market?

The upward trend in coronary artery disease occurrences is anticipated to augment the expansion of the angina market in the future. Coronary artery disease (CAD), also referred to as coronary heart disease (CHD) or ischemic heart disease (IHD), is a medical condition where the coronary arteries, which provide blood, oxygen, and nutrients to the heart muscle, become narrowed or blocked. The surge in instances of coronary artery disease is attributed to shifts in lifestyle habits, environmental influences, and genetic components. Angina holds a vital function in detecting and studying the widespread presence of coronary artery disease. Its detection paves the way for medical assessment and diagnosis, aids in risk stratification, influences treatment approaches, and guides public health initiatives. For instance, the American Heart Association revealed in January 2023 that the population of adults living with CAD in the U.S. escalated from 18.2 million to an estimated 19.3 million between 2021 and 2022. Consequently, the mounting instances of coronary artery diseases act as a catalyst for the growth of the angina market.

How Is the Angina Market Segmented?

The anginamarket covered in this report is segmented –

1) By Type: Angina Pectoris; Unstable Angina; Prinzmetal Angina; Other Types

2) By Treatment: Lifestyle Changes; Medications; Angioplasty And Stenting; Coronary Bypass Surgery; Other Treatments

3) By Drug Class: Beta Blockers; Nitrates And Calcium Channel Blockers; Angiotensin-Converting Enzyme Inhibitors; Other Drug Classes

4) By Application: Clinics; Hospitals; Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina; Chronic Stable Angina; Effort-Induced Angina; Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina; Pre-Infarction Angina; Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina; Coronary Artery Spasm-Induced Angina; Variant Angina

4) By Other Types: Nocturnal Angina; Post-Infarction Angina; Angina With Silent Myocardial Ischemia; Angina Due To Aortic Stenosis Or Valve Disease

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Which Regions Are Driving the Next Phase of the Angina Market Growth?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Angina Market?

Leading firms in the angina market are focusing on the creation of innovative medicines such as metoprolol tartrate tablets, aiming to improve the treatment of conditions associated with coronary artery disease (CAD) like angina. Metoprolol tartrate is a widely prescribed medication for diverse cardiovascular conditions including angina, hypertension, and heart failure. For instance, in April 2023, the India-based pharmaceutical entity, Zydus, got the green light from the United States Food and Drug Administration (US-FDA) to produce and distribute its generic equivalent of Metoprolol Tartrate Tablets USP with potencies of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is utilized for managing several cardiovascular issues, mainly high blood pressure and angina and to enhance survival rates post heart attack.

View the full report here:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

How Is the Angina Market Defined and What Are Its Core Parameters?

Angina, also known as angina pectoris, is a medical condition characterized by chest pain or discomfort, typically caused by insufficient blood flow to the heart muscle. It inadequate blood flow is usually a result of blockages or narrowing of the coronary arteries due to atherosclerosis.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Angina Market From 2025 To 2029?

In recent times, there has been a significant growth in the market size of angina. There is a projected growth from $10.71 billion in 2024 to $11.4 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.4%. Factors contributing to growth during the historic period include a rise in coronary heart disease occurrence, heightened use of vasodilators, an increased incidence of myocardial ischemia, enhancements in diagnostic abilities, and a surge in the utilization of imaging techniques.

What Is the Projected Market Size of the Angina Market?

The market size for angina is projected to experience robust growth in the upcoming years, estimated to reach $14.44 billion in 2029 with a compound annual growth rate (CAGR) of 6.1%. The projected growth in the forecast period can be connected to the increasing occurrence of chronic angina pectoris, a surge in drug approvals and clinical research, heightened demand for retail pharmacies, growing consciousness about cardiovascular health, and escalating demand for medications. Key trends in the forecast period encompass technological progress in early diagnosis, advancements in procedures like angioplasty and stenting, innovative gene therapy methods, demand for coronary stents, and improvements in the treatment of coronary artery disease.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Who are the Major Competitors in the Angina Market Outlook?

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

What Is Fueling Growth in the Angina Market?

The growth of the angina market going forward is expected to be spurred by the escalating incidences of coronary artery diseases. Coronary artery disease (CAD), also referred to as coronary heart disease (CHD) or ischemic heart disease (IHD), is a condition manifested by the constriction or obstruction of the coronary arteries that facilitate the supply of blood, oxygen, and nutrients to the heart muscle. The upward trend of coronary artery disease (CAD) incidences can be attributed to alterations in lifestyle and environmental and genetic influences. Angina is crucial in pinpointing and grasping the prevalence of coronary artery disease. Its existence necessitates medical assessment and diagnosis, aids in categorizing risk, directs treatment options, and shapes public health policies. For example, data from the American Heart Association in January 2023 showed that the population of adults in the U.S. enduring Coronary artery disease (CAD) escalated from 18.2 million to nearly 19.3 million between 2021 and 2022. Consequently, the surge in coronary artery diseases propels the angina market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Which Angina Market Segments Are Growing the Fastest?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Which Industry Trends Are Shaping the Future of the Angina Market?

Major players in the angina market are working on the development of ground-breaking medicines like metoprolol tartrate tablets, aimed at offering efficient and specialised treatments for patients suffering from Coronary Artery Disease (CAD) and other related conditions. Metoprolol tartrate tablets are a frequently utilized medication for treating several heart-related conditions, spanning angina (chest pain), hypertension (high blood pressure) and heart failure. To illustrate, in April 2023, the Indian pharmaceutical firm, Zydus, acquired the final endorsement from the US Food and Drug Administration (US-FDA) for the production and distribution of its generic Metoprolol Tartrate Tablets USP, available in dosages of 25 mg, 50 mg, and 100 mg. Metoprolol is a beta-blocker administered to manage various cardiovascular ailments, comprising high blood pressure (hypertension), and chest pain (angina), as well as to enhance the chances of survival following a heart attack.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Countries Are Leading the Angina Market?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337

This Report Delivers Insight On:

1. How big is the angina market, and how is it changing globally?

2. Who are the major companies in the angina market, and how are they performing?

3. What are the key opportunities and risks in the angina market right now?

4. Which products or customer segments are growing the most in the angina market?

5. What factors are helping or slowing down the growth of the angina market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the angina industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Estimated Market Size of the Angina Market In 2029?#_x000D_

The angina market has witnessed robust growth lately. It is predicted to expand from $10.71 billion in 2024 to $11.4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The surge in the historical period can be linked to the rising occurrence of coronary heart disease, higher utilization of vasodilators, an increased rate of myocardial ischemia, enhanced diagnostic proficiency, and amplified use of imaging technologies._x000D_

_x000D_

In the coming years, a robust expansion is expected in the angina market size, projected to reach $14.44 billion in 2029, with a compound annual growth rate (CAGR) of 6.1%. Factors boosting growth in this period include a higher incidence of chronic angina pectoris, an upsurge in drug approvals and clinical research, increased demand in retail pharmacies, escalating awareness around cardiovascular health, and a heightened demand for medicines. Key trends for this forecast period encompass advancements in early diagnostic technology, progress in angioplasty and stenting, the emergence of new gene therapy methodologies, rising demand for coronary stents, and breakthroughs in the treatment of coronary artery disease._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp_x000D_

_x000D_

#What Are the Primary Drivers Supporting the Market Growth of the Angina Market?#_x000D_

The growth of the angina market is anticipated to surge due to the increasing instances of coronary artery diseases. Coronary artery disease (CAD), also recognized as coronary heart disease (CHD) or ischemic heart disease (IHD), is a disease characterized by the shortening or obstruction of the coronary arteries, which deliver blood, oxygen, and vital nutrients to the heart muscle. The escalation of coronary artery disease (CAD) cases can be attributed to changes in lifestyle, as well as environmental and genetic factors. Angina serves an essential role in detecting and comprehending the frequency of coronary artery disease. Its existence triggers medical assessment and diagnosis, aids with risk stratification, directs treatment choices, and shapes public health tactics. For instance, as noted by the American Heart Association in January 2023, the quantity of adults living with Coronary artery disease (CAD) in the U.S. grew from 18.2 million in 2021 to roughly 19.3 million in 2022. Thus, the uptick in cases of coronary artery diseases propels the angina market._x000D_

_x000D_

#Which Primary Segments of the Angina Market Are Driving Growth and Industry Transformations?#_x000D_

The angina market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types_x000D_

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments_x000D_

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes_x000D_

4) By Application: Clinics, Hospitals, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina_x000D_

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina_x000D_

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina_x000D_

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the Angina Market?#_x000D_

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Key Market Trends in the Angina Market Over the Coming Years?#_x000D_

Leading businesses in the angina market are focusing on the development of cutting-edge drugs like metoprolol tartrate tablets which are aimed at bringing about advanced and targeted therapies for patients grappling with coronary artery disease (CAD) and associated ailments. Metoprolol tartrate tablets are a widely-used medication type designed to treat numerous cardiovascular issues, encompassing angina (chest pain), hypertension (elevated blood pressure), and heart failure. For instance, in April 2023, Zydus, a pharmaceutical company operating out of India, was granted the final green light by the United States Food and Drug Administration (US-FDA) to produce and sell their generic variant of Metoprolol Tartrate Tablets USP with dosages of 25 mg, 50 mg, and 100 mg. Metoprolol is a beta blocker that’s employed in the treatment of a range of cardiovascular conditions, inclusive of high blood pressure (hypertension), and chest pain (angina), and is also used to enhance the chances of survival post a cardiac arrest._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/angina-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Angina Market?#_x000D_

Angina, also known as angina pectoris, is a medical condition characterized by chest pain or discomfort, typically caused by insufficient blood flow to the heart muscle. It inadequate blood flow is usually a result of blockages or narrowing of the coronary arteries due to atherosclerosis._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Angina Market?

The upward trend in coronary artery disease cases is anticipated to fuel the growth of the angina market. Coronary artery disease (CAD), often called coronary heart disease (CHD) or ischemic heart disease (IHD), is a health condition defined by the narrowing or blockage of the coronary arteries responsible for supplying blood, oxygen, and nutrients to the heart muscle. This increase in CAD is attributed to lifestyle modifications as well as environmental and genetic factors. Angina serves as a crucial factor in detecting and acknowledging the prevalence of coronary artery disease. The appearance of angina triggers medical assessment and diagnosis, assists in risk stratification, aids in making treatment choices, and shapes public health policies. For example, the American Heart Association noted in January 2023 that the number of adults in the US living with CAD increased from 18.2 million to roughly 19.3 million between 2021 and 2022. Consequently, the growing occurrences of coronary artery diseases are propelling the angina market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

How Will the Growth Rate of theAngina Market Impact Industry Trends by 2034?

The market size for angina has seen a robust growth in the past few years. It’s expected to swell from $10.71 billion in 2024 to $11.4 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.4%. The significant growth in the previous years is due to higher incidence rates of coronary heart disease, more frequent use of vasodilators, a rise in myocardial ischemia prevalence, enhanced diagnostic methodologies, and an uptick in the employment of imaging techniques.

In the coming years, robust growth is anticipated in the angina market, reaching $14.44 billion in 2029 with a compound annual growth rate (CAGR) of 6.1%. The growth during the projected period can be credited to factors such as the escalating incidence of chronic angina pectoris, an increase in drug approvals and clinical studies, and a surging demand for retail pharmacies. Also driving the market’s growth are increasing recognition of cardiovascular health and an expanding demand for medications. Key trends in the projected period encompass innovation in early detection, progress in angioplasty and stenting procedures, the emergence of new gene therapy methods, a rising demand for coronary stents, and breakthroughs in treatments for coronary artery diseases.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337

What Are the Most Significant Market Trends Transforming theAngina Market?

Leading enterprises in the angina market are focusing on creating innovative pharmaceuticals such as metoprolol tartrate tablets, aiming to offer improved, tailor-made remedies for individuals suffering from coronary artery disease (CAD) and similar issues. Metoprolol tartrate tablets are often prescribed for a range of cardiovascular diseases, including angina (chest discomfort), hypertension (elevated blood pressure), and heart failure. For example, Zydus, a pharmaceutical corporation based in India, secured the final consent from the United States Food and Drug Administration (US-FDA) in April 2023. This approval allows Zydus to produce and distribute its generic Metoprolol Tartrate Tablets USP in concentrations of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is utilized for treating numerous cardiovascular complications, including elevated blood pressure (hypertension) and chest discomfort (angina), and to enhance life expectancy post-heart attack.

What Are the Top Market Players Propelling the Growth of theAngina Industry?

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Primary Segments of the Angina Market Are Driving Growth and Industry Transformations?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Angina Market?# Market?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Angina Market 2025, By The Business Research Company:

Medical Device Security Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-device-security-global-market-report

Generative AI In Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Egg Freezing And Embryo Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/egg-freezing-and-embryo-banking-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the angina market?

The angina market has grown strongly in recent years. It will increase from $10.71 billion in 2024 to $11.4 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. This growth is linked to the increased prevalence of coronary heart disease, greater use of vasodilators, higher rates of myocardial ischemia, improved diagnostic capabilities, and the expanded use of imaging techniques.

What will be the angina market size in the future?

The angina market is projected to grow strongly, reaching $14.44 billion by 2029 with a CAGR of 6.1%. The growth is driven by the rising prevalence of chronic angina pectoris, drug approvals, clinical research, greater awareness of cardiovascular health, and rising medication demand. Key trends include technological advancements in early diagnosis, angioplasty and stenting innovations, gene therapy approaches, demand for coronary stents, and advancements in coronary artery disease treatments.

Get your angina market report here!

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

What main drivers are fueling expansion in the angina market?

The growing prevalence of coronary artery diseases is expected to stimulate the growth of the angina market. Coronary artery disease (CAD) involves the narrowing of the coronary arteries, leading to heart-related complications. The rise in CAD is linked to lifestyle changes, genetics, and environmental factors. Angina is a critical indicator of CAD and aids in diagnosis, treatment planning, and public health strategies. For example, in January 2023, the American Heart Association reported that CAD cases in the US increased from 18.2 million in 2021 to 19.3 million in 2022. The rising incidence of CAD is driving the angina market.

What key areas define the segmentation of the global angina market?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Who are the dominant players expanding their reach in the angina market?

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

How are evolving market trends shaping angina Strategies?

Companies in the angina market are developing innovative medications like metoprolol tartrate tablets to offer more effective treatments for coronary artery disease (CAD) and related conditions. Metoprolol tartrate tablets are used to treat cardiovascular issues, including angina and hypertension. In April 2023, Zydus, an India-based pharmaceutical company, received US-FDA approval to market its generic version of Metoprolol Tartrate Tablets in 25 mg, 50 mg, and 100 mg strengths. Metoprolol, a beta blocker, is commonly prescribed to treat cardiovascular conditions and improve survival rates after a heart attack.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16337

Which regions are emerging as leaders in the angina market?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Medical Device Security Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-device-security-global-market-report

Generative AI In Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Egg Freezing And Embryo Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/egg-freezing-and-embryo-banking-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the CAGR of the Angina Market Influence Its Overall Growth by 2034?

The market for angina has seen significant expansion in the last few years. It is projected to rise from a value of $10.71 billion in 2024 to $11.4 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.4%. The notable growth noted in this historic period is ascribed to the surge in incidences of coronary heart disease, heightened use of vasodilators, rising prevalence of myocardial ischemia, advancements in diagnostic tests, and more frequent usage of imaging techniques.

The market for angina is predicted to experience substantial expansion in the coming years, with its value reaching $14.44 billion in 2029, reflecting a compound annual growth rate (CAGR) of 6.1%. Factors contributing to growth during this forecast period include a rising number of chronic angina pectoris cases, heightened drug approvals and clinical research, increased need for retail pharmacies, rising cardiovascular health consciousness, and growing medication demand. Notable trends during the forecast period are anticipated improvements in early diagnosis technology, angioplasty and stenting advancements, emerging gene therapy strategies, increased demand for coronary stents, and progress in coronary artery disease treatment.

What Combination of Drivers Is Leading to Accelerated Growth in the Angina Market?

The increase in heart-related diseases such as coronary artery diseases is projected to boost the growth of the angina market in the future. Coronary artery disease (CAD), also known as coronary heart disease (CHD) or ischemic heart disease (IHD), is defined by the constriction or obstruction of coronary arteries that provide blood, oxygen, and essential nutrients to the cardiac muscle. Changing lifestyle habits, environmental factors, and genetic predisposition have contributed to an increase in coronary artery disease (CAD). The presence of angina plays a significant role in recognizing and comprehending the prevalence of coronary artery disease, prompting medical evaluations and diagnoses, assisting in risk stratification, defining treatment strategies, and shaping public health policy. In a report by the American Heart Association in January 2023, the number of adults in the U.S with Coronary artery disease (CAD) saw an increase from 18.2 million in 2021 to roughly 19.3 million in 2022. Therefore, these rising instances of coronary artery diseases are propelling the angina market.

Explore Comprehensive Insights Into The Global Angina Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Who Are the Leading Companies Pioneering Change in the Angina Market?

Major companies operating in the angina market are:

• Pfizer Inc.

• Johnson & Johnson

• F. Hoffmann-La Roche AG

• Merck & Co Inc.

• Bayer AG

What Are the Most Significant Trends Transforming the Angina Market Today?

Major firms in the angina market, are working on innovative medication like metoprolol tartrate tablets, aimed at providing more potent and specific treatment methods for patients suffering from coronary artery disease (CAD) and related ailments. Metoprolol tartrate tablets are a typical medication prescribed for various heart-related conditions, including angina, hypertension, and heart failure. For instance, Zydus, a pharmaceutical entity based in India, gained final approval from the US Food and Drug Administration (US-FDA) in April 2023 to produce and sell its Metoprolol Tartrate Tablets USP generic variant in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is used to manage various cardiovascular issues, including hypertension and angina, as well as to enhance survival rates post-heart attack.

Secure Your Global Angina Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Market Segments Are Driving Strategic Growth and Trends in the Angina Market?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Which Regions Are Leading the Charge in Angina Market Development?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Definition of the Angina Market Impacting Future Growth?

Angina, also known as angina pectoris, is a medical condition characterized by chest pain or discomfort, typically caused by insufficient blood flow to the heart muscle. It inadequate blood flow is usually a result of blockages or narrowing of the coronary arteries due to atherosclerosis.

Browse Through More Similar Reports By The Business Research Company:

Medical Device Security Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-device-security-global-market-report

Generative AI In Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Egg Freezing And Embryo Banking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/egg-freezing-and-embryo-banking-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: